CClinicalTrials.gg
CompletedNCT04682496Updated Feb 8, 2023

Ultrasound Probe Pressure on the Intratendon Doppler Signal in Patellar Tendinopathy

An interventional study of Intratendon vascularization in Patellar Tendinitis, sponsored by Cardenal Herrera University. Completed at 1 site in Spain. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-02-08.

Sponsored by Cardenal Herrera University · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years to 65 Years
Sex
All
01

Study summary

In the sports field, patellar tendinopathy is, as a pathology, one of the main concerns for athletes, both because of its incidence and because of the difficulty involved in their recovery. At the ultrasound level, tendinopathies can be divided, depending on the presence or absence of an intratendon Doppler signal, into hypervascular or hypovascular tendinopathy. Its classification is, today and clinically speaking, merely qualitative through the observation of the explorer. The ultrasound evaluation is carried out through a probe that is placed on the patient's skin, the procedure to be followed to obtain a vascular image is merely operator-dependent, that is, the position of the probe, the pressure exerted on the skin or even ultrasound optimization parameters can drastically modify the results.

Due to high pressure on the probe, the intratendon Doppler signal may be diminished in the quantitative variables of area, number of signals, pixel intensity, perimeter, solidity, perfusion index, circularity, major and minor diameter.

From a certain pressure on the probe, the intratendon Doppler signal can be drastically altered.

This study will try to evaluate the influence of the pressure exerted by the examiner with the probe on the quantitative variables of the intratendon Doppler signal in patellar tendinopathy.

To carry out the study, a single group with patellar tendinopathy will be established. Ultrasound evaluations with Doppler mode will be performed on the tendon using different probe pressures, monitoring the applied force and recording the images obtained for later analysis.

02

Conditions studied

  • Patellar Tendinitis

Browse trials for

03

In context

Tendinopathy

413 studies on the registry are indexed under Tendinopathy; 64 are open to participants now.

This study's enrollment of 30 is below the median of 50 across 339 interventional studies indexed under Tendinopathy.

Browse Tendinopathy studies →

Lead sponsor

Cardenal Herrera University is the lead sponsor of 104 studies on the registry; 23 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Acceptance of participation in the study.
  • Diagnosis of patellar tendinopathy with the presence of an intratendon Doppler signal.
  • Subjects between the ages of 18 and 65.

Exclusion criteria

Exclusion Criteria:

  • Present some type of surgical intervention in the region to be explored that could alter in some way the ultrasound evaluation.
  • Refer vascular pathology or the intake of medication that may alter blood flow or density.
  • Having been treated with sclerosing techniques that can alter the perfusion or vascular resistance of the tendon tissue.
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    intratendon vascularization

    Intratendon vascularization will be quantified using a proprietary methodology using ImageJ 1.47v image analysis software, determining the different variables related to the Doppler signal within an intratendon region of interest.

    Procedure: Intratendon vascularization

Interventions

  • ProcedureIntratendon vascularization

    Ultrasonic exploration by power-Doppler of the intratratendon vascularization, making longitudinal cuts of the patellar tendon and with previously pre-established Doppler optimization parameters for all patients. The optimization parameters of the power-Doppler signal will be set at a Doppler frequency of 6.7 MHz, pulse repetition frequency (PRF) of 0.7 kHz. The lowest wall filter and a standardized gain just below the level that produces random noise will be applied. This examination will be repeated several times with different probe pressures, which will be quantitatively adjusted through the force sensor and maintained with the articulated arm. A 4-second static video will be recorded of the longitudinal section that presents a higher Doppler signal in each of the scans at different probe pressures.

06

What researchers measure

Primary outcomes

  1. number of signals (n)

    number of intratendon doppler signals (unit)

    Time frame: during intervention

  2. Average pixel intensity (0-255 Units on a scale)

    average pixel color intensity (0-255 Units on a scale)

    Time frame: during intervention

  3. Area (mm^2)

    intratendon Doppler signal area (mm\^2)

    Time frame: during intervention

  4. Perimeter (mm)

    perimeter of the intratendon Doopler signal (mm)

    Time frame: during intervention

  5. major diameter (mm)

    major diameter of the intratendon Doppler signal (mm)

    Time frame: during intervention

  6. minor diameter (mm)

    minor diameter of the intratendon Doppler signal (mm)

    Time frame: during intervention

  7. Circularity

    measure of roundness or circularity, area-to perimeter ratio. (0-1 Units on a scale)

    Time frame: during intervention

  8. Solidity

    measures the density of an object (0-1 Units on a scale)

    Time frame: during intervention

  9. Resistance index

    resistance index of intratendon Doppler signals (0-1 Units on a scale)

    Time frame: during intervention

  10. Force

    force applied by the probe on the knee during the scan (N)

    Time frame: during intervention

Secondary outcomes

  1. Age (years)

    subject's age (years)

    Time frame: Post-intervention

  2. Sex (female or male)

    subject's sex (female or male)

    Time frame: post-intervention

  3. Time of evolution (months)

    time since the patient had the first symptoms (months)

    Time frame: months

  4. Dominance

    Dominant leg (right-left)

    Time frame: post-intervention

  5. Pain location

    Location of pain in the patellar tendon (lower pole of the patella-body of the tendon-insertion in the anterior tuberosity of the tibia)

    Time frame: Immediately pre-intervention

  6. Victorian Institute of Sport Assessment-Patella (VISA-P)

    Knee pain and function rating scale (0-100 Units on a scale). The maximum score possible is 100 points and represents an asymptomatic athlete who can fully engage in sports. The theoretical minimum is 0 point. The test is carried out just before the intervention to relate the results of the Doppler quantification with the severity of the pain.

    Time frame: Immediately pre-intervention

  7. hours of training (hours)

    Current training hours per week (hours). This question is asked just before the intervention in order to relate the results of the Doppler quantification with the hours of training performed

    Time frame: Immediately pre-intervention

  8. Time without training (months)

    time without training (months). This question is asked just before the intervention.

    Time frame: Immediately pre-intervention

07

Study locations

1 site
  • Ceu Cardenal Herrera University
    Elche, Alicante 03204, Spain
08

References and documents

Publications

  • Hernandez-Sanchez S, Hidalgo MD, Gomez A. Cross-cultural adaptation of VISA-P score for patellar tendinopathy in Spanish population. J Orthop Sports Phys Ther. 2011 Aug;41(8):581-91. doi: 10.2519/jospt.2011.3613. Epub 2011 Jul 12. PubMed 21765223 ↗
  • Dhyani M, Roll SC, Gilbertson MW, Orlowski M, Anvari A, Li Q, Anthony B, Samir AE. A pilot study to precisely quantify forces applied by sonographers while scanning: A step toward reducing ergonomic injury. Work. 2017;58(2):241-247. doi: 10.3233/WOR-172611. PubMed 28922185 ↗
  • Malliaras P, Chan O, Simran G, Martinez de Albornoz P, Morrissey D, Maffulli N. Doppler ultrasound signal in Achilles tendinopathy reduces immediately after activity. Int J Sports Med. 2012 Jun;33(6):480-4. doi: 10.1055/s-0032-1304636. Epub 2012 Apr 12. PubMed 22499574 ↗
  • Boesen AP, Boesen MI, Torp-Pedersen S, Christensen R, Boesen L, Holmich P, Nielsen MB, Koenig MJ, Hartkopp A, Ellegaard K, Bliddal H, Langberg H. Associations between abnormal ultrasound color Doppler measures and tendon pain symptoms in badminton players during a season: a prospective cohort study. Am J Sports Med. 2012 Mar;40(3):548-55. doi: 10.1177/0363546511435478. Epub 2012 Feb 9. PubMed 22328709 ↗

Study documents

  • Protocol, analysis plan and consent form · Dec 12, 2020

Documents are hosted by the registry — open the source record to download them.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04682496
Lead sponsor
Cardenal Herrera University
Responsible party
SERGIO MONTERO NAVARRO (Principal Investigator, Cardenal Herrera University) — Principal investigator
First posted
Dec 23, 2020
Start date
Dec 18, 2020
Primary completion
Aug 30, 2022
Completion
Feb 7, 2023
Last update
Feb 8, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion